AusPAR: Ixekizumab

Australian Public Assessment Report

AusPAR

AusPAR: Ixekizumab [PDF, 1.5 MB]

AusPAR: Ixekizumab [Word, 2.21 MB]

Attachment: Product Information: Ixekizumab [PDF, 478.74 KB]

Attachment: Product Information: Ixekizumab [Word, 411.52 KB]

Device/Product Name

Taltz

Active ingredients

Ixekizumab

AusPAR Date

19 November 2018

Published

15 January 2019

Submission Number

PM-2017-02078-1-3

Submission Type

Extension of indications

Decision

Approved